{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:25:21Z","timestamp":1789647921404,"version":"4.0.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP124589"],"award-info":[{"award-number":["OPP124589"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Task Force for Global Health"},{"name":"Neglected Tropical Diseases Modelling Consortium","award":["OPP1053230"],"award-info":[{"award-number":["OPP1053230"]}]},{"name":"Neglected Tropical Diseases Modelling Consortium","award":["OPP1184344"],"award-info":[{"award-number":["OPP1184344"]}]},{"DOI":"10.13039\/501100003246","name":"Netherlands Organisation for Scientific Research","doi-asserted-by":"crossref","award":["016.Veni.178.023"],"award-info":[{"award-number":["016.Veni.178.023"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The World Health Organization currently recommends assessing elimination of onchocerciasis by testing whether Ov16 antibody prevalence in children aged 0\u20139 years is below 0.1%. However, the certainty of evidence for this recommendation is considered to be low. We used the established ONCHOSIM model to investigate the predictive value of different Ov16-antibody prevalence thresholds in various age groups for elimination of onchocerciasis in a variety of endemic settings and for various mass drug administration scenarios. According to our simulations, the predictive value of Ov16 antibody prevalence for elimination depends highly on the precontrol epidemiologic situation, history of mass drug administration, the age group that is sampled, and the chosen Ov16-antibody prevalence threshold. The Ov16 antibody prevalence in children aged 5\u201314 years performs best in predicting elimination. Appropriate threshold values for this age group start at 2.0% for very highly endemic areas; for lower-endemic areas, even higher threshold values are safe to use. Guidelines can be improved by sampling school-aged children, which also is operationally more feasible than targeting children under age 10 years. The use of higher threshold values allows sampling of substantially fewer children. Further improvement can be achieved by taking a differentiated sampling approach based on precontrol endemicity.<\/jats:p>","DOI":"10.1093\/aje\/kwz109","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T19:49:35Z","timestamp":1556567375000},"page":"1723-1732","source":"Crossref","is-referenced-by-count":26,"title":["Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis"],"prefix":"10.1093","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-2264","authenticated-orcid":false,"given":"Luc E","family":"Coffeng","sequence":"first","affiliation":[{"name":"Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma A","family":"Stolk","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Golden","sequence":"additional","affiliation":[{"name":"PATH, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala","family":"de los Santos","sequence":"additional","affiliation":[{"name":"PATH, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo J","family":"Domingo","sequence":"additional","affiliation":[{"name":"PATH, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sake J","family":"de Vlas","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"2019091012175098000_kwz109C1","author":"African Programme for Onchocerciasis Control","year":"2010"},{"key":"2019091012175098000_kwz109C2","author":"World Health Organization","year":"2012"},{"issue":"11","key":"2019091012175098000_kwz109C3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.pt.2015.06.007","article-title":"Diagnostic tools for onchocerciasis elimination programs","volume":"31","author":"Vlaminck","year":"2015","journal-title":"Trends Parasitol"},{"key":"2019091012175098000_kwz109C4","author":"World Health Organization","year":"2016"},{"issue":"2","key":"2019091012175098000_kwz109C5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4269\/ajtmh.2008.79.239","article-title":"Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan","volume":"79","author":"Rodr\u00edguez-P\u00e9rez","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"2019091012175098000_kwz109C6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4269\/ajtmh.2007.77.334","article-title":"Elimination of Onchocerca volvulus transmission in the Santa Rosa focus of Guatemala","volume":"77","author":"Lindblade","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"2019091012175098000_kwz109C7","first-page":"21","article-title":"Guide to detecting a potential recrudescence of onchocerciasis during the posttreatment surveillance period: the American paradigm","volume":"3","author":"Program Coordinating Committee and OEPA staff","year":"2012","journal-title":"Res Rep Trop Med"},{"issue":"1","key":"2019091012175098000_kwz109C8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4269\/ajtmh.2008.78.147","article-title":"Evidence for suppression of Onchocerca volvulus transmission in the Oaxaca focus in Mexico","volume":"78","author":"Rodr\u00edguez-P\u00e9rez","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"2019091012175098000_kwz109C9","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1371\/journal.pntd.0000404","article-title":"Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala","volume":"3","author":"Gonzalez","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2019091012175098000_kwz109C10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.2010.09-0626","article-title":"Lack of active Onchocerca volvulus transmission in the northern Chiapas focus of Mexico","volume":"83","author":"Rodr\u00edguez-P\u00e9rez","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"2019091012175098000_kwz109C11","doi-asserted-by":"crossref","first-page":"638429","DOI":"10.1155\/2012\/638429","article-title":"Elimination of Onchocerca volvulus transmission in the Huehuetenango focus of Guatemala","volume":"2012","author":"Cruz-Ortiz","year":"2012","journal-title":"J Parasitol Res"},{"issue":"5","key":"2019091012175098000_kwz109C12","doi-asserted-by":"crossref","first-page":"e2821","DOI":"10.1371\/journal.pntd.0002821","article-title":"Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution","volume":"8","author":"Lovato","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2019091012175098000_kwz109C13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.actatropica.2009.04.001","article-title":"The elimination of the vector Simulium neavei from the Itwara onchocerciasis focus in Uganda by ground larviciding","volume":"111","author":"Garms","year":"2009","journal-title":"Acta Trop"},{"key":"2019091012175098000_kwz109C14","doi-asserted-by":"crossref","first-page":"748540","DOI":"10.1155\/2012\/748540","article-title":"Transmission of onchocerciasis in Wadelai focus of northwestern Uganda has been interrupted and the disease eliminated","volume":"2012","author":"Katabarwa","year":"2012","journal-title":"J Parasitol Res"},{"issue":"2","key":"2019091012175098000_kwz109C15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4269\/ajtmh.13-0546","article-title":"Serosurveillance to monitor onchocerciasis elimination: the Ugandan experience","volume":"90","author":"Oguttu","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"2019091012175098000_kwz109C16","doi-asserted-by":"crossref","first-page":"e3113","DOI":"10.1371\/journal.pntd.0003113","article-title":"Status of onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision","volume":"8","author":"Evans","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2019091012175098000_kwz109C17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1186\/s13071-016-1779-8","article-title":"Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes","volume":"9","author":"Hern\u00e1ndez-Gonz\u00e1lez","year":"2016","journal-title":"Parasit Vectors"},{"issue":"7","key":"2019091012175098000_kwz109C18","doi-asserted-by":"crossref","first-page":"e0004829","DOI":"10.1371\/journal.pntd.0004829","article-title":"Evidence for suppression of onchocerciasis transmission in Bioko Island, Equatorial Guinea","volume":"10","author":"Moya","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2019091012175098000_kwz109C19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4269\/ajtmh.16-0274","article-title":"The first confirmed elimination of an onchocerciasis focus in Africa: Abu Hamed, Sudan","volume":"95","author":"Zarroug","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"2019091012175098000_kwz109C20","doi-asserted-by":"crossref","first-page":"e69231","DOI":"10.1371\/journal.pone.0069231","article-title":"Extended result reading window in lateral flow tests detecting exposure to Onchocerca volvulus: a new technology to improve epidemiological surveillance tools","volume":"8","author":"Golden","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"2019091012175098000_kwz109C21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1128\/CVI.00227-15","article-title":"Rapid point-of-contact tool for mapping and integrated surveillance of Wuchereria bancrofti and Onchocerca volvulus infection","volume":"22","author":"Steel","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"2019091012175098000_kwz109C22","doi-asserted-by":"crossref","first-page":"e0005314","DOI":"10.1371\/journal.pntd.0005314","article-title":"Modelling anti-Ov16 IgG4 antibody prevalence as an indicator for evaluation and decision making in onchocerciasis elimination programmes","volume":"11","author":"Lont","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2019091012175098000_kwz109C23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0169-2607(90)90030-D","article-title":"ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis","volume":"31","author":"Plaisier","year":"1990","journal-title":"Comput Methods Programs Biomed"},{"issue":"4","key":"2019091012175098000_kwz109C24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0001-706X(91)90015-C","article-title":"The reproductive lifespan of Onchocerca volvulus in West African savanna","volume":"48","author":"Plaisier","year":"1991","journal-title":"Acta Trop"},{"issue":"2","key":"2019091012175098000_kwz109C25","first-page":"169","article-title":"The risk and dynamics of onchocerciasis recrudescence after cessation of vector control","volume":"69","author":"Plaisier","year":"1991","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2019091012175098000_kwz109C26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/infdis\/172.1.204","article-title":"Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa","volume":"172","author":"Plaisier","year":"1995","journal-title":"J Infect Dis"},{"issue":"3","key":"2019091012175098000_kwz109C27","first-page":"237","article-title":"Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in West Africa","volume":"75","author":"Plaisier","year":"1997","journal-title":"Bull World Health Organ"},{"key":"2019091012175098000_kwz109C28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2458-1-12","article-title":"Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination","volume":"1","author":"Alley","year":"2001","journal-title":"BMC Public Health"},{"issue":"5","key":"2019091012175098000_kwz109C29","first-page":"384","article-title":"Can ivermectin mass treatments eliminate onchocerciasis in Africa?","volume":"80","author":"Winnen","year":"2002","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2019091012175098000_kwz109C30","doi-asserted-by":"crossref","first-page":"e2032","DOI":"10.1371\/journal.pntd.0002032","article-title":"African programme for onchocerciasis control 1995\u20132015: model-estimated health impact and cost","volume":"7","author":"Coffeng","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"2019091012175098000_kwz109C31","doi-asserted-by":"crossref","first-page":"e2759","DOI":"10.1371\/journal.pntd.0002759","article-title":"African programme for onchocerciasis control 1995\u20132015: updated health impact estimates based on new disability weights","volume":"8","author":"Coffeng","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"2019091012175098000_kwz109C32","doi-asserted-by":"crossref","first-page":"e115886","DOI":"10.1371\/journal.pone.0115886","article-title":"Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment","volume":"9","author":"Coffeng","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2019091012175098000_kwz109C33","doi-asserted-by":"crossref","first-page":"e0003664","DOI":"10.1371\/journal.pntd.0003664","article-title":"Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa","volume":"9","author":"Kim","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2019091012175098000_kwz109C34","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s13071-015-1159-9","article-title":"Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis","volume":"8","author":"Stolk","year":"2015","journal-title":"Parasit Vectors"},{"issue":"5001","key":"2019091012175098000_kwz109C35","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.2011741","article-title":"An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection","volume":"251","author":"Lobos","year":"1991","journal-title":"Science"},{"key":"2019091012175098000_kwz109C36","author":"McDonald","year":"2014"},{"key":"2019091012175098000_kwz109C37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s13071-016-1623-1","article-title":"Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis","volume":"9","author":"Golden","year":"2016","journal-title":"Parasit Vectors"},{"issue":"3","key":"2019091012175098000_kwz109C38","doi-asserted-by":"crossref","first-page":"e0006249","DOI":"10.1371\/journal.pntd.0006249","article-title":"Rethinking the serological threshold for onchocerciasis elimination","volume":"12","author":"Gass","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"2019091012175098000_kwz109C39","doi-asserted-by":"crossref","first-page":"e0006624","DOI":"10.1371\/journal.pntd.0006624","article-title":"The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: model explorations for onchocerciasis","volume":"12","author":"de Vos","year":"2018","journal-title":"PLoS Negl Trop Dis"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/advance-article-pdf\/doi\/10.1093\/aje\/kwz109\/28905999\/kwz109.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/188\/9\/1723\/29586240\/kwz109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T21:29:12Z","timestamp":1569965352000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/188\/9\/1723\/5486395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,5,7]]},"published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwz109","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,5,7]]}}}